This week's Fierce Biotech is brought to you by Allucent.

Advancing Patient Selection in Oncology: Enrichment Strategies and Emerging Diagnostics

Live Webinar:
Jun 10, 2025 11:00am ET

Join a live webinar of leading industry experts as they explore how advances in biomarker science and companion diagnostics are transforming oncology trials. From Phase I onward, sponsors now have powerful tools to identify and enroll patients most likely to benefit, accelerating timelines, improving trial efficiency, and driving better outcomes. Join this session to learn:

How emerging diagnostic technologies are informing early-stage patient selection

Real-world strategies for enrichment that improve trial efficiency and reduce risk

Best practices for integrating biomarkers and companion diagnostics into clinical design

Insights from oncology development experts on what’s working—and what’s next—in a rapidly evolving therapeutic landscape

You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.

Fierce LifeSciences is a division of Questex LLC.
1111B S Governors Ave, Suite 25792 Dover, DE, 19904
© 2025 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.